Document Detail

Overlap of functional dyspepsia and GERD-diagnostic and treatment implications.
MedLine Citation:
PMID:  23296247     Owner:  NLM     Status:  Publisher    
GERD and functional dyspepsia are the two most prevalent upper gastrointestinal disorders. Gastro-oesophageal reflux is most commonly diagnosed using the cardinal symptoms of heartburn and regurgitation. Patients might also be diagnosed using a questionnaire, after empiric treatment with an acid suppressant, after upper endoscopy or by pH testing. Functional dyspepsia is best diagnosed using symptoms outlined by the Rome committee in conjunction with a normal upper endoscopy. Theoretically, distinguishing these two populations should be easy for all health-care providers. In reality, however, carefully separating out these two populations can be quite difficult, as substantial overlap exists epidemiologically, symptomatically and even diagnostically. This overlap renders precise diagnosis a challenge; given the limited treatment options, the primary goal is to identify those patients who will respond to acid suppressive therapy. Despite the frequency with which functional dyspepsia and GERD overlap, remarkably few studies have investigated this overlap. Most recommendations are based on data derived from separate studies of functional dyspepsia and GERD. A further limitation of existing studies is their failure to differentiate between the various diagnostic categories into which the individual presenting with heartburn might belong.
Eamonn M M Quigley; Brian E Lacy
Related Documents :
8484667 - Assessment of lupus: where are we now?
19664287 - The revised fibromyalgia impact questionnaire (fiqr): validation and psychometric prope...
25004197 - The relative contribution of cognition and symptomatic remission to functional outcome ...
22943487 - Efficacy of psychoeducation on symptomatic and functional recovery in bipolar disorder.
17610727 - Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjust...
10629357 - A 6-month, double-blind, placebo-controlled trial of eptastigmine in alzheimer's disease.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-08
Journal Detail:
Title:  Nature reviews. Gastroenterology & hepatology     Volume:  -     ISSN:  1759-5053     ISO Abbreviation:  Nat Rev Gastroenterol Hepatol     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101500079     Medline TA:  Nat Rev Gastroenterol Hepatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Indacaterol 75 ?g once daily for the treatment of patients with chronic obstructive pulmonary diseas...
Next Document:  Diagnosis and management of polycystic liver disease.